Functional analysis of the human D5 dopamine receptor missense and nonsense variants: Differences in dopamine binding affinities

Pharmacogenetics

Volumn 9, Issue 2, 1999, Pages 199-206

  Cravchik, Anibal ^a,c   Gejman, Pablo V ^b  

^a National Institute on Alcohol and Alcoholism   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CELERA GENOMICS   (United States)

Author keywords

Affinity; Dopamine; Neuroleptics; Schizophrenia

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALANINE; ASPARAGINE; ASPARTIC ACID; CYSTEINE; DOPAMINE; DOPAMINE 5 RECEPTOR; GLUTAMINE; LEUCINE; PHENYLALANINE; PROLINE; RISPERIDONE; SERINE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; DNA POLYMORPHISM; DRUG BINDING; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PHARMACOGENETICS; PRIORITY JOURNAL; RECEPTOR GENE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CLONING, MOLECULAR; COS CELLS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION, MISSENSE; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RISPERIDONE;

ANIMALIA; TRIXIS;

EID: 0032803472     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Asghari V, Schools O, van Kats S, Ohara K, Jovanovic V, Guan HC, et al. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol 1994; 46:364-373.
2. Barbanti P, Bronzetti E, Ricci A, Cerbo R, Fabbrini G, Buzzi MG, et al. Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci Lett 1996; 207:73-76.
3. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui LC. Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome. Am J Med Genet 1997; 74:58-61.
4. Cheng YC, Prusoff WH. Relationship between the inhibiton (150) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-3108.
5. Cichon S, Nothen MM, Erdmann J, Propping P. Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene. Hum Mol Genet 1994a; 3:209.
6. Cichon S, Nothen MM, Rietschel M, Korner J, Propping P, Nothen MM, et al. Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Biol Psychiatry 1994b; 36:850-853.
7. Cichon S, Nothen MM, Catalano M, Di Bella D, Maier W, Lichtermann D, et al. Single-strand conformation analysis (SSCA) of the dopamine D1 receptor gene (DRD1) reveals no significant mutation in patients with schizophrenia and manic depression. Psychiatr Genet 1995; 5:97-103.
8. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993; 33:281-307.
9. Cravchik A, Sibley DR, Gejman PV. Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants. Pharmacogenetics 1999; 9:17-23.
10. Feng J, Sobell JL, Heston LL, Cook EH, Goldman D, Sommer SS. Analysis of the dopamine D1 and D5 receptors by restriction endonuclease fingerprinting (REF) in patients with neuropsychiatric disease reveals missense change in a highly conserved amino acid. Am J Med Genet 1998; 81:172-178.
11. Grandy DK, Allen LJ, Yuan Z, Magenis RE, Civelli O. Chromosomal localization of three human D5 dopamine receptor genes. Genomics 1992; 13:968-973.
12. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, et al. No structural mutation in the dopamine D2 receptor gene in alcholholism or schizophrenia. Analysis using denaturing gradient gel eclectrophoresis. JAMA 1994; 271:204-208.
13. Goldman-Rakic PS. Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory In: Carrol BJ, Barrett EJ, editor. Psychopathology and the brain. New York: Raven Press; 1991. pp. 1-23.
14. Grandy DK, Zhang YA, Bouvier C, Zhou QY, Johnson RA, Allen L, et al. Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci USA 1991; 88:9175-9179.
15. Huang YY, Kandel ER. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus [see comments]. Proc Natl Acad Sci USA 1995; 92:2446-2450.
16. Kalsi G, Sherrington R, Mankoo BS, Brynjolfsson J. Sigmundsson T, Curtis D, et al. Linkage study of the D5 dopamine receptor gene (DRD5) in muliplex Icelandic and English schizophrenia pedigrees. Am J Psychiatry 1996; 153:107-109.
17. Lannfelt L, Sokoloff P, Martes MP, Pilon C, Giros B, Jonsson E, et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 1992; 2:249-256.
18. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993; 2:767-773.
19. Lidow MS, Goldman-Rakic PS. Down-regulation of the D1 and D5 dopamine receptors in the primat prefrontal cortex by chronic treatment with antipsychotic drugs. Proc Natl Acad Sci USA 1994; 91:4353-4356.
20. Lidow MS, Elsworlh JD, Goldman-Rakic PS. A common action of clozapine, haloperidol and remoxipride on D1- and D2- dopamine receptors in the primate cerebral cortex. J Pharmacol Exp Ther 1997; 281:597-603.
21. Liu Q, Sobell JL, Heston LL, Sommer SS. Screening the dopamine D1 receptor gene 1131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence, changes. Am J Med Genet 1995; 60:165-171.
22. Mansour A, Meng F, Meador-VVoodruff JH, Taylor LP, Civelli O, Akil O. Site-directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol Mol Pharmacol 1992; 227:205-214.
23. Neve KA, Cox BA, Henningsen RA, Spanoyannis A, Neve RL. Pivotal role for aspartate-80 in the regulation of D2 receptor affinity for drugs and inhibition of adenyly cyclase. Mol Pharmacol 1991; 39:733-739.
24. Neve KA, Henningsen RA, Kozell LB, Cox BA, Neve RL, Structure- function analysis of dopamine D2 receptors by in vitro mutagenesis. In: Niznik HB, editor. Dopamine receptors and transporters. New York: Dekker; 1994. pp. 299-321.
25. Neve KA, Neve RL. Molecular biology of dopamine receptors. In: Neve KA, Neve RL, editors. The dopamine receptors. Totowa, NJ: Humana Press; 1997. pp. 27-76.
26. Nothen MM, Cichon S, Hemmer S, Hebebrand J, Remschmidt H, Lehmkuhl G, et al. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet 1994; 3:2207-2212.
27. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in two widespread areas of the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatr 1995; 52:808-818.
28. Sibley DR, Monsma FJ. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992; 13:61-69.
29. Sobell JL, Lind TJ. Sigurdson DC, Zald DH, Snitz BE, Grove WM, et al. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet 1995; 4:507-514.
30. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, Nature 1991; 350:614-619.
31. Tiberi M, Caron MG. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 1994; 269:27925-27931.
32. Tomic M, Seeman P, George SR, O'Dowd BF, Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. Biochem Biophys Res Cummin 1993; 191:1020-1027.
33. Vanyukov MM, Moss HB, Gioio AE, Hughes HB, Kaplan BB, Tarter RE. An association between the microsatellite polymorphism at the DRD5 gene and the liability to substance abuse: pilot study. Behavior Genetics 1998; 28:75-82.
34. Williams NM, Cardno AG, Murphy KC, Jones LA, Asherson P, MCGuffin P, Owen MJ, Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene. Psychiatr Genet 1997; 7:83-85.